65 results
425
MEIP
MEI Pharma Inc
19 Jul 23
Business combination disclosure
4:03pm
companies, including on counterparties, the supply chain, the execution of clinical development programs, access to financing and the allocation
8-K
EX-99.1
MEIP
MEI Pharma Inc
19 Jul 23
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
4:02pm
, the supply chain, the execution of clinical development programs, access to financing and the allocation of government resources; (xvii) final data from pre
425
MEIP
MEI Pharma Inc
18 Jul 23
Business combination disclosure
5:26pm
industry and individual companies, including on counterparties, the supply chain, the execution of clinical development programs, access to financing … and Infinity’s industry and individual companies, including on counterparties, the supply chain, the execution of clinical development programs, access
8-K
EX-99.2
MEIP
MEI Pharma Inc
18 Jul 23
Other Events
5:20pm
, the supply chain, the execution of clinical development programs, access to financing and the allocation of government resources; (xvii) final data
8-K
stxjjn ptzn
18 Jul 23
Other Events
5:20pm
425
o7iphs7ozl5hkaak
17 Jul 23
Business combination disclosure
4:03pm
8-K
ev2u6xgv 83hnzr
17 Jul 23
MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
4:02pm
8-K
EX-99.1
ud6nmy2
17 Jul 23
MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
4:02pm
424B3
lpbsgx3u
13 Jul 23
Prospectus supplement
4:19pm
425
943ym978louh 5k68l
13 Jul 23
Business combination disclosure
4:17pm
8-K
EX-99.1
5l14u9csbwa936
13 Jul 23
MEI Pharma Postpones Special Meeting of Shareholders
4:15pm
8-K
s79z0
13 Jul 23
MEI Pharma Postpones Special Meeting of Shareholders
4:15pm
425
vifxbod
7 Jul 23
Business combination disclosure
4:53pm
8-K
u0a4bv0bm1fcj9j2
7 Jul 23
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
4:51pm
8-K
EX-99.1
ier2c3 wpeov
7 Jul 23
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
4:51pm
425
ryxe y7rs
5 Jul 23
Business combination disclosure
5:08pm
8-K
gfvultanmn6e680
5 Jul 23
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to
5:07pm
8-K
EX-99.1
y395zp3vw 6agrspfd
5 Jul 23
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to
5:07pm
424B3
dr2xh s4xx3sda9bmfx
3 Jul 23
Prospectus supplement
4:56pm